Literature DB >> 12138120

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.

Morihiro Matsuda1, Iichiro Shimomura, Masataka Sata, Yukio Arita, Makoto Nishida, Norikazu Maeda, Masahiro Kumada, Yoshihisa Okamoto, Hiroyuki Nagaretani, Hitoshi Nishizawa, Ken Kishida, Ryutaro Komuro, Noriyuki Ouchi, Shinji Kihara, Ryozo Nagai, Tohru Funahashi, Yuji Matsuzawa.   

Abstract

Obesity is more linked to vascular disease, including atherosclerosis and restenotic change, after balloon angioplasty. The precise mechanism linking obesity and vascular disease is still unclear. Previously we have demonstrated that the plasma levels of adiponectin, an adipose-derived hormone, decreases in obese subjects, and that hypoadiponectinemia is associated to ischemic heart disease. In current the study, we investigated the in vivo role of adiponectin on the neointimal thickening after artery injury using adiponectin-deficient mice and adiponectin-producing adenovirus. Adiponectin-deficient mice showed severe neointimal thickening and increased proliferation of vascular smooth muscle cells in mechanically injured arteries. Adenovirus-mediated supplement of adiponectin attenuated neointimal proliferation. In cultured smooth muscle cells, adiponectin attenuated DNA synthesis induced by growth factors including platelet-derived growth factor, heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), basic fibroblast growth factor, and EGF and cell proliferation and migration induced by HB-EGF. In cultured endothelial cells, adiponectin attenuated HB-EGF expression stimulated by tumor necrosis factor alpha. The current study suggests an adipo-vascular axis, a direct link between fat and artery. A therapeutic strategy to increase plasma adiponectin should be useful in preventing vascular restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138120     DOI: 10.1074/jbc.M206083200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  196 in total

Review 1.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 2.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Nectar from adipocytes.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2003-07       Impact factor: 4.599

4.  Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues.

Authors:  Sylvaine Cases; Ping Zhou; Jonathan M Shillingford; Bryony S Wiseman; Jo Dee Fish; Christina S Angle; Lothar Hennighausen; Zena Werb; Robert V Farese
Journal:  Development       Date:  2004-05-26       Impact factor: 6.868

5.  Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.

Authors:  Min Ding; Ana Catarina Carrão; Robert J Wagner; Yi Xie; Yu Jin; Eva M Rzucidlo; Jun Yu; Wei Li; George Tellides; John Hwa; Tamar R Aprahamian; Kathleen A Martin
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

6.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

7.  Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.

Authors:  Daniel Antonio de Luis; Rocío Aller; B de la Fuente; D Primo; Rosa Conde; Olatz Izaola; Manuel Gonzalez Sagrado
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

8.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

Authors:  Katarzyna Dunajska; Andrzej Milewicz; Diana Jedrzejuk; Jadwiga Szymczak; Wiktor Kuliczkowski; Piotr Salomon; Dariusz Bialy; Karol Poczatek; Przemysław Nowicki
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

10.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.

Authors:  J Frystyk; L Tarnow; T Krarup Hansen; H-H Parving; A Flyvbjerg
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.